Table 1.
Baseline characteristics of the patient population (n = 150)
| Characteristic | Value |
|---|---|
| Age (years, mean ± SD) | 66 ± 10 |
| Male gender, n (%) | 114 (76) |
| Ischaemic cardiomyopathy | 101 (67) |
| New York Heart Association functional class III, n (%) | 115 (77) |
| LVEF (%, mean ± SD) | 27 ± 8 |
| QRS duration (ms, mean ± SD) | 160 ± 32 |
| Cardiovascular risk factors, n (%) | |
| Diabetes | 32 (21) |
| Hypertension | 59 (39) |
| Hypercholesterolaemia | 52 (35) |
| Smoking | 81 (54) |
| Family history of coronary artery disease | 58 (39) |
| Medication, n (%) | |
| Diuretic | 131 (87) |
| Angiotensin-converting enzyme inhibitor/angiotensin II antagonist | 137 (91) |
| Beta-blocker | 109 (73) |
| Statin | 99 (66) |